Instructions for Flebaven 500 [Phlebodia 600]
Release Form
Film-coated tablets
Description Flebaven 500
The tablets are covered with a film shell of light orange-pink color, capsule-shaped, double-convex; the view on the fracture is a rough mass from yellow to brown-yellow color with a film shell of light orange-pink color.
1 tab.
purified micronized flavonoid fraction* 500 mg,
including diosmin 450 mg (90%)
hesperidin-translated flavonoids 50 mg (10%)
* as purified micronized flavonoid fraction, granule substance - 613 mg.
Auxiliary substances of the granule substance: microcrystalline cellulose - 82 mg, povidone K30 - 31 mg.
Auxiliary substances: sodium carboxymethylstarch - 27 mg, talc - 6 mg, magnesium stearate - 4 mg.
Film sheath composition: Opadray orange 03H32599 (Hypromellose - 71.714%, titanium dioxide (E171) - 15.936%, talc - 6.972%, propylene glycol - 4.98%, iron oxide yellow (E172) - 0.332%, iron oxide red (E172) - 0.066%).
ATC codes
C05CA53 Diosmin in combination with other drugs
Clinical-pharmacological groups / Group affiliation Flebaven 500
Venotonising preparation
Active substance
- diosmin
- hesperidin
Pharmaco-therapeutic group Phlebodia 600
Venotonising and venoprotective agent
Pharmacological effect Flebaven 500
The combined agent, which has an angioprotective and venotonising effect, comprises bioflavonoids. The invention makes it possible to reduce the stretchability of veins, to increase the tonus thereof and to reduce venous stasis, to reduce the permeability and brittle size of capillaries and to increase the resistance thereof, and to improve microcirculation and lymphatic drainage.
When used systematically, it reduces the expression of clinical manifestations of chronic venous insufficiency of the lower extremities of organic and functional nature.
Testimony Flebaven 500
- Symptomatic therapy of venous insufficiency of the lower extremities: feeling of heaviness and pain in the legs.
- Symptomatic therapy of acute hemorrhoids.
Method of use, course and dosage Phlebodia 600
Taken inside.
For venous lymphatic failure, the daily dose is 900 mg of diosmin + 100 mg of hesperidine. The duration of the meal is two times/day (in the middle of the day and in the evening during the meal).
For acute hemorrhoids, the daily dose is .2.7 g of diosmine + 300 mg of hesperidine (2 morning and evening doses) for the first four days, and the daily dose is 1.8 g of diosmine + 200 mg of hesperidine (2 morning and evening doses) for the next three days.
- Nosology (ICD codes)
- I87.2
- Venous insufficiency (chronic) (peripheral)
- K64
- Hemorrhoids and perianal venous thrombosis
